LABCORP HOLDINGS INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
LABCORP HOLDINGS INC. (LH) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.19 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2026-02-24
- LABCORP HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2025 was -$1.19B.
- LABCORP HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2024 was -$1.37B.
- LABCORP HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2023 was -$1.15B.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|
| 2025-12-31 | -$1.19B 10-K · filed 2026-02-24 |
| 2024-12-31 | -$1.37B 10-K · filed 2026-02-24 |
| 2023-12-31 | -$1.15B 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |